- Home
- PCVX vs KFY Comparison
PCVX vs KFY Comparison
Compare PCVX & KFY Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- PCVX
- KFY
- Stock Information
- Founded
- PCVX 2013
- KFY 1969
- Country
- PCVX United States
- KFY United States
- Employees
- PCVX N/A
- KFY N/A
- Industry
- PCVX Biotechnology: Pharmaceutical Preparations
- KFY Diversified Commercial Services
- Sector
- PCVX Health Care
- KFY Consumer Discretionary
- Exchange
- PCVX Nasdaq
- KFY Nasdaq
- Market Cap
- PCVX 4.0B
- KFY 3.4B
- IPO Year
- PCVX 2020
- KFY 1999
- Fundamental
- Price
- PCVX $45.43
- KFY $65.16
- Analyst Decision
- PCVX Strong Buy
- KFY Buy
- Analyst Count
- PCVX 7
- KFY 2
- Target Price
- PCVX $101.67
- KFY $80.00
- AVG Volume (30 Days)
- PCVX 1.4M
- KFY 411.5K
- Earning Date
- PCVX 11-04-2025
- KFY 12-04-2025
- Dividend Yield
- PCVX N/A
- KFY 2.94%
- EPS Growth
- PCVX N/A
- KFY 33.45
- EPS
- PCVX N/A
- KFY 4.69
- Revenue
- PCVX N/A
- KFY $2,763,755,000.00
- Revenue This Year
- PCVX N/A
- KFY $4.39
- Revenue Next Year
- PCVX N/A
- KFY $4.42
- P/E Ratio
- PCVX N/A
- KFY $13.95
- Revenue Growth
- PCVX N/A
- KFY 0.93
- 52 Week Low
- PCVX $27.66
- KFY $59.23
- 52 Week High
- PCVX $107.22
- KFY $80.64
- Technical
- Relative Strength Index (RSI)
- PCVX 61.99
- KFY 39.34
- Support Level
- PCVX $40.14
- KFY $63.66
- Resistance Level
- PCVX $45.90
- KFY $66.65
- Average True Range (ATR)
- PCVX 2.14
- KFY 1.60
- MACD
- PCVX -0.28
- KFY -0.22
- Stochastic Oscillator
- PCVX 90.21
- KFY 20.72
About PCVX Vaxcyte Inc.
Vaxcyte Inc is a clinical-stage vaccine innovation company engineering high-fidelity vaccines to protect humankind from the consequences of bacterial diseases. It is developing broad-spectrum conjugate and novel protein vaccines to prevent or treat bacterial infectious diseases. Its product comprises of Pneumococcal conjugate vaccine. The firm's product candidate consists of VAX-31, VAX-24, VAX-A1, VAX-PG, VAX-GI, and Others.
About KFY Korn Ferry
Korn Ferry is a consulting firm that powers performance. The Company helps unlock the potential in people and unleash transformation across organizations synchronizing, operations, and talent to accelerate performance, fuel growth, and inspire a legacy of change. The company's segment includes Consulting, Digital, Executive Search North America, Executive Search EMEA, Executive Search APAC, Executive Search Latin America, Professional Search & Interim and RPO. The company generates the majority of its revenue from the Executive Search segment and Consulting segment. The Executive search segment helps organizations recruit board-level, chief executive, and other C-suite/senior executive and general management talent to deliver lasting impact.